HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardium.

Abstract
The effects of the new inotropic agents saterinone, sulmazole, UD-CG 212.Cl and milrinone at A1 adenosine receptors and m-cholinoceptors were evaluated in human myocardium from patients with heart failure. At A1 adenosine receptors, all compounds inhibited 3H-DPCPX-binding to ventricular membrane preparations at micromolar concentrations. As judged from the K1-values, the rank order of potency was saterinone greater than sulmazole greater than UD-CG 212.Cl greater than milrinone. The new inotropic agents also displaced the binding of 3H-QNB at m-cholinoceptors. Except for saterinone, the concentration ranges of mean Ki-values were considerably higher at m-cholinoceptors than at A1 adenosine receptors. The rank order of potency was saterinone greater than sulmazole greater than UD-CG 212.Cl greater than milrinone. Competition of the A1 adenosine receptor agonist R-PIA to 3H-DPCPX-binding showed a biphasic curve with a shallow slope (Hill coefficient nH = 0.63) and revealed two affinity states of the A1 adenosine receptor. In the presence of guanine nucleotides [Gpp(NH)p], the competition curve showed one low affinity class of binding sites and was shifted to the right. In contrast, the competition curves of the new inotropic agents were characterized by a monophasic, steeper slope (mean Hill coefficient nH = 0.98). Guanine nucleotides had no effect. Similar results were obtained with saterinone and carbachol at m-cholinoceptors. Competition with carbachol revealed three affinity states of the m-cholinoceptor, the super-high affinity binding was reversed by Gpp(NH)p. Competition with saterinone revealed one class of binding sites which was not influenced by Gpp(NH)p.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsM Ungerer, M Böhm, R H Schwinger, E Erdmann
JournalNaunyn-Schmiedeberg's archives of pharmacology (Naunyn Schmiedebergs Arch Pharmacol) Vol. 341 Issue 6 Pg. 577-85 (Jun 1990) ISSN: 0028-1298 [Print] Germany
PMID2392160 (Publication Type: Journal Article)
Chemical References
  • Cardiotonic Agents
  • Imidazoles
  • Piperazines
  • Pyridazines
  • Pyridones
  • Receptors, Cholinergic
  • Receptors, Purinergic
  • Xanthines
  • Guanylyl Imidodiphosphate
  • Quinuclidinyl Benzilate
  • UD CG 212 Cl
  • 1,3-dipropyl-8-cyclopentylxanthine
  • sulmazole
  • Milrinone
  • saterinone
Topics
  • Adult
  • Binding, Competitive (drug effects)
  • Cardiotonic Agents (antagonists & inhibitors)
  • Electric Stimulation
  • Guanylyl Imidodiphosphate (pharmacology)
  • Heart (drug effects)
  • Heart Failure (metabolism)
  • Humans
  • Imidazoles (pharmacology)
  • In Vitro Techniques
  • Membranes (drug effects, metabolism)
  • Milrinone
  • Myocardium (metabolism)
  • Piperazines (pharmacology)
  • Pyridazines (pharmacology)
  • Pyridones (pharmacology)
  • Quinuclidinyl Benzilate
  • Receptors, Cholinergic (drug effects)
  • Receptors, Purinergic (drug effects)
  • Xanthines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: